Senzime participated at the International Anesthesia Research Society Annual meeting, IARS

Washington DC May 6-9, 2017

Washington May 9. Senzime participated at the International Anesthesia Research Society Annual meeting, IARS. Senzime exhibited TetraGraph and Professor Sorin Brull made a poster presentation on the topic.

“This meeting has been a great success for Senzime with a lot of interest in our TetraGraph and the upcoming market launch. There is a huge need for a precise and easy to use monitor to reduce complications and shorten hospital stays, says Lena Söderström, CEO Senzime.

Link to the poster

About Us

Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of $10 billion. The company's shares are listed on AktieTorget (ATORG: SEZI) www.senzime.com

Subscribe

Documents & Links